Share Name Share Symbol Market Type Share ISIN Share Description
BTG Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +1.50p +0.23% 665.50p 665.50p 666.50p 668.50p 660.50p 661.50p 310,410 16:29:55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 570.5 31.6 8.7 76.5 2,567.10

BTG Share Discussion Threads

Showing 4801 to 4823 of 4825 messages
Chat Pages: 193  192  191  190  189  188  187  186  185  184  183  182  Older
DateSubjectAuthorDiscuss
13/8/2017
21:08
We have lacked good press coverage for a few years . Still surprised every article still links BTG as being well known as the snake bite andedote company. I for one think this is either sloppy journalism or sloppy interviews by BTG.
bargainbob
13/8/2017
20:21
Time for being pedantic here. Picture shows a woman holding a bottle of some cleaning fluid and the man is holding two bottles with his attention elsewhere. Neither is wearing proper lab equipment, no safety glasses, coat not buttoned up. All the containers on the overcrowded bench are general lab chemicals. Time to sort out the photo library methinks 😀 I'm all for this type of product expansion. Diversification is what we need and this type of partnership would be ideal, though any benefits to the bottom elite would be seen in five years plus..
dr biotech
13/8/2017
17:37
All grist to the mill!Let's see more of these initiatives.That's what market leadership is about.
fhmktg
13/8/2017
02:15
I wonder if it is AstraZenca who will join the partnership from the drug perspective. Expansion of our Phillips device partnership , I suspect is also a positive.
bargainbob
12/8/2017
19:59
See IO article here: http://www.telegraph.co.uk/business/2017/08/12/drugmaker-btg-bets-devices-help-treat-cancer/
cockneytrader
11/8/2017
16:47
AQR has been the main shorter of BTG.(The egregious JP Morgan has also been desultorily in and out, amongst others) Has this activity and their general strategy benefited AQR's shareholders? As I surmised, the answer is "not at all"! Here is an excerpt from a rigorous examination by IFA.com of AQR's expensive expertise: "Performance Analysis The next question we address is whether investors can expect superior performance in exchange for the higher costs associated with AQR’s “skill.” We compare each of the 3 strategies that have at least 3 years of performance history since inception and against its current Morningstar assigned benchmark to see just how well each has delivered on their perceived value proposition. We have included alpha charts for each strategy at the bottom of this article. Here is what we found: 67% (16 funds) have underperformed their respective benchmarks since inception, having delivered a NEGATIVE alpha 33% (8 funds) have outperformed their respective benchmarks since inception, having delivered a POSTIVE alpha 0% (0 funds) have outperformed their respective benchmarks consistently enough since inception to provide 95% confidence that such outperformance will persist as opposed to being based on random outcomes Based on the historical performance of their strategies, it seems AQR has not provided superior returns for their investors. The vast majority of their funds have failed to outperform their Morningstar assigned benchmark. The inclusion of statistical significance is key to this exercise as it indicates which outcome is the most likely vs. random-chance outcomes." Why do they bother? Because their charges to gullible investors are extortionate and not related to performance. As BTG shareholders we have been unfortunate that the vultures have descended on us. OK,OK, there is, of course, nothing new here.
muffmitz
11/8/2017
16:08
Back to 640 adejuk.
bargainbob
10/8/2017
12:00
It did not , sorry it fell after I posted.
bargainbob
10/8/2017
08:40
I should have added " ...if it holds!" :-)
spyder
10/8/2017
08:05
There you go spyder a small bounce up
bargainbob
10/8/2017
05:30
You are probably all heartily fed-up with me banging on about charts etc, but ... the recent up-trend from 540p does seem to have been broken, more by the passage of time than any significant drop in the share price. I know the fundamentalists (I am one) will argue that this is all nonsense, however, I do feel that in the absence of news, it is momentum that drives this share price and charts do help to predict where the momentum will take the shares next. A small bounce up would be very good news in this regard I feel.
spyder
10/8/2017
00:45
How strange! I was in Alameda, Penumbra's home, a few hours ago on my way to Berkeley University. Even more strangely I had, just before that, bought a lump of BTG at around the same price. Synchronicity: an omen perchance?
muffmitz
10/8/2017
00:29
This from Martin Waller (Tempus) in today's Times. "And finally . . . Numis Securities is encouraged by the read across from second-quarter figures from Penumbra, an American pharmaceuticals group, to BTG, the London-listed company arguably if unfairly best known for its snake venom treatment. Penumbra, which lifted revenues by a quarter, and BTG overlap in places, in particular in less invasive treatments for blood clots through the latter’s Ekos treatment. This is part of BTG’s interventional medicine division, the fastest-growing part of the business." As it happens, I bought a fair amount yesterday at 6.44. Here's hoping that the current manipulation downwards will soon be defeated.
harijan
09/8/2017
20:05
uglad i lost £120k on this [in today's money] on black friday 2003. i am too old to go through that again i am hoping for £10 by next summer well done you.
adejuk
08/8/2017
14:47
This share has been a remarkable one for me. One of my few non dividend investments being of an age where income has much relevance. True for a time it was performing as if there was no risk trading on pe's that were close to dot com ratios in the past. Fortunately it smashed through my maximum holding levels so I top sliced having doubled. I went into this share in 2012 after hearing the CEO discuss her "vision". She is still working on a FTSE 100 position and increasing interventional medicines to 70% of the portfolio while still growing others. These two alone imply growth in the share price. I liked the way she answered the questions no waffling and I thought she showed clarity of thought. So happy to wait even if it will be two years before I need to top slice again.
ugandalad
08/8/2017
14:46
This share has been a remarkable one for me. One of my few non dividend investments being of an age where income has much relevance. True for a time it was performing as if there was no risk trading on pe's that were close to dot com ratios in the past. Fortunately it smashed through my maximum holding levels so I top sliced having doubled. I went into this share in 2012 after hearing the CEO discuss her "vision". She is still working on a FTSE 100 position and increasing interventional medicines to 70% of the portfolio while still growing others. These two alone imply growth in the share price. I liked the way she answered the questions no waffling and I thought she showed clarity of thought. So happy to wait even if it will be two years before I need to top slice again.
ugandalad
08/8/2017
14:45
This share has been a remarkable one for me. One of my few non dividend investments being of an age where income has much relevance. True for a time it was performing as if there was no risk trading on pe's that were close to dot com ratios in the past. Fortunately it smashed through my maximum holding levels so I top sliced having doubled. I went into this share in 2012 after hearing the CEO discuss her "vision". She is still working on a FTSE 100 position and increasing interventional medicines to 70% of the portfolio while still growing others. These two alone imply growth in the share price. I liked the way she answered the questions no waffling and I thought she showed clarity of thought. So happy to wait even if it will be two years before I need to top slice again.
ugandalad
08/8/2017
07:45
Certainty that is a level , but not new for BTG , I remember the days it traded very much above that.
bargainbob
07/8/2017
15:55
bb £10 will do me
adejuk
07/8/2017
09:09
https://youtu.be/sirkSUAb8u0
steeplejack
07/8/2017
07:26
On meet the CEO Louise talks about getting Btg to the next level .Then the level above that . What is the next level FTSE or something else. I hate ill defined sound bytes. So what do we think is the next level ?
bargainbob
04/8/2017
07:39
Good interview , though forgetting shareholders during the mass expansion to get the footsie goal.
bargainbob
03/8/2017
17:28
Next year Adejuk , it's our year pal.
bargainbob
Chat Pages: 193  192  191  190  189  188  187  186  185  184  183  182  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170821 16:02:03